PeptidePicker

Trust & transparency

Meet PeptidePicker's Editorial Team

Our science writers and licensed medical reviewers help readers make sense of peptide research—clearly, carefully, and without hype.

Who we are

We're a small team of science communicators and clinicians with decades of combined experience in research literacy, pharmacology, and evidence appraisal. We love turning dense papers into guidance you can actually use—while staying honest about what we know, what we don't, and where your own care team fits in.

Our work is grounded in primary sources, transparent limitations, and plain language. Every long-form guide is reviewed by a licensed clinician before publication.

How we measure quality

  • Clinical review on every guide before publication
  • Disclosure of conflicts and commercial relationships where relevant
  • Clear distinction between educational content and individualized medical advice
Jordan Ellis

Editorial leadership

Jordan Ellis

MS, Science Communication

Lead science editor

Jordan translates primary literature into plain language for PeptidePicker. Former university research communicator with a focus on endocrinology and pharmacology. Editorial content is educational only and does not replace individualized medical advice.

Full profile

Clinical review

Medical reviewers

Licensed clinicians who review our guides for accuracy, safety framing, and appropriate scope—so you can read with more confidence. Review does not create a patient–provider relationship.

Dr. Sarah Mitchell

Medical reviewer

Dr. Sarah Mitchell

PharmD, BCPS

Board-certified pharmacotherapy specialist with 12+ years in peptide-adjacent therapeutics education. Reviews PeptidePicker guides for accuracy of drug-class context, labeling conventions, and patient-safety messaging. Does not establish a clinician–patient relationship through this site.

View profile
Dr. Michael Ortiz

Medical reviewer

Dr. Michael Ortiz

MD

Internal medicine–trained physician contributing clinical review for educational articles. Interests include metabolic therapy literacy and helping readers understand what trials can and cannot prove. Not your treating physician.

View profile
Dr. Priya Nair

Medical reviewer

Dr. Priya Nair

MD, PhD

Physician-scientist who reviews content for alignment with mainstream pharmacology and research ethics framing. Emphasizes jurisdiction-specific regulation and the limits of general web content. Clinical decisions belong with your care team.

View profile

Science communication

Science writers

Writers translate research into clear language—always with citations, caveats, and respect for what remains uncertain.

Riley Brooks

Staff writer

Riley Brooks

BS, Biochemistry

Riley focuses on consumer safety framing, sourcing red flags, and regulatory context at a high level. Passionate about clear disclaimers and separating marketing from data. Not a substitute for your own clinician or legal counsel.

View profile

Independence

What shapes our coverage?

You do. As we work to explain peptide science responsibly, our team is committed to editorial independence.

That means we put readers first when we decide what to publish, which sources to cite, and how to frame uncertainty.

We put readers first when we determine:

  • Which topics we cover—and which claims we refuse to amplify without evidence.
  • Which studies and authorities we cite, and how we handle conflicting data.
  • How we describe risks, benefits, and regulatory context in your jurisdiction.
  • What we explain in plain language—and what belongs in a conversation with your clinician.

Our editorial standards are non-negotiable: accuracy, transparency, and respect for the limits of general web content.

Team portraits use illustrative stock photography for visual consistency; they are not representations of private individuals in named editorial roles.